SEC Tracker
Get the app

Vistagen Therapeutics VTGN

Vistagen amends executive severance plan

Form
8-K
Filed
Importance
Routine
  1. Amended plan effective Oct 7, 2026
  2. Expands severance benefits for involuntary terminations
  3. Includes COBRA premium payments
  4. Requires 12 months of full-time employment

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vistagen Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Agenus AGEN public float $135M, Jun 30, 2025
  2. Voyager Therapeutics VYGR public float $144M, Jun 30, 2025
  3. Eledon Pharmaceuticals ELDN public float $145M, Jun 30, 2025
  4. Puma Biotechnology PBYI public float $145M, Jun 30, 2025
  5. Neurogene NGNE public float $146M, Jun 30, 2025